RxDoctor Payments DataLook up a doctor →

Stephen Brunton, MD

Family Medicine · Winnsboro, SCNPI 1134116957

Payments from drug & device makers

$1,300,198in general payments, 2019–2025

Across 1,631 payments — averaging $797.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$415K
  • Novo Nordisk$167K
  • AstraZeneca$142K
  • Astrazeneca UK Limited$74K
  • Acadia Pharmaceuticals Inc$71K
  • Abbott$71K
  • plus $361K from 33 others

What the payments were for

  • Consulting fees$428,59433%
  • Speaking & faculty fees$711,35055%
  • Travel & lodging$132,09310%
  • Food & beverage$26,2182%
  • Education$1,5260%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,300,198 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$5,822
Medicare patients
39
Services billed
258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin34$24,034
XareltoRivaroxaban24$15,606
FarxigaDapagliflozin Propanediol18$14,483
EliquisApixaban11$9,653
Atorvastatin Calcium65$616
Albuterol Sulfate HfaAlbuterol Sulfate17$437
Tamsulosin Hcl31$432
Rosuvastatin Calcium47$373
Levothyroxine Sodium35$362
Pioglitazone Hcl12$348
Gabapentin24$253
Famotidine12$221
Glipizide ErGlipizide12$194
Amlodipine Besylate57$161
Losartan Potassium17$110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$46,667$24,03434 claims
AstraZenecaFarxiga$142,045$14,48318 claims
Mylan Inc.Atorvastatin Calcium$4,704$61665 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Winnsboro

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →